WallStreetZenWallStreetZen

NASDAQ: MCTA
Charming Medical Revenue

OverviewEarningsRevenue
DividendOwnership
Charming Medical revenue was N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, MCTA annual revenue was $6.2M, with 3.4% growth year-over-year.

MCTA revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when MCTA announces revenue.

MCTA Revenue History By Year

MCTA Yearly RevenueMCTA RevenueMCTA ChangeMCTA Revenue Growth
2025-03-31$6.22M$206.38k+3.43%
2024-03-31$6.02MN/AN/A

1 of 1

Charming Medical Revenue FAQ

What was Charming Medical's annual revenue growth in the past year?

As of Q2 2026, Charming Medical's revenue has grown null year over year. Charming Medical's revenue in the past year totaled N/A.

How much does Charming Medical make in a year?

Charming Medical's revenue by year for the past one years is:
  • Charming Medical's revenue for the twelve months ending Mar 31, 2025 was $6.22 million, a 3.43% increase year over year.

What was Charming Medical's revenue in 2025?

Charming Medical's annual revenue for the twelve months ending Mar 31, 2025 was $6.22 million, a 3.43% increase year over year.

How much does Charming Medical make in a day?

Based on Charming Medical annual revenue for the past one years, MCTA makes an average of $17,045.89 per day.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.